HCW Biologics Inc. (HCWB) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    HCW Biologics Inc.

    NASDAQ: HCWB · Real-Time Price · USD
    4.24
    -0.39 (-8.42%)
    At close: Sep 05, 2025, 3:59 PM
    4.36
    2.83%
    After-hours: Sep 05, 2025, 07:48 PM EDT

    HCW Biologics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -30.02M -24.99M -14.9M -12.86M
    Depreciation & Amortization
    		 1.18M 1.14M 717.85K 543.6K
    Stock-Based Compensation
    		 1.01M 1M 1.12M 360.98K
    Other Working Capital
    		 775.08K -5.14M 2.35M -2.8M
    Other Non-Cash Items
    		 -418 4.98M 188.46K -473.22K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 13.6M -4.64M 2.49M 1.46M
    Operating Cash Flow
    		 -14.23M -22.51M -10.39M -10.98M
    Capital Expenditures
    		 -261.62K -6.2M -10.28M -47.26K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a -34.97M
    Sales Maturities Of Investments
    		 n/a 10M 24.98M n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -261.62K 3.8M 14.71M -35.02M
    Debt Repayment
    		 6.79M -38.27K 6.45M n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 2.32M n/a -190.55K -6.76M
    Financial Cash Flow
    		 15.57M -14.53K 6.27M 49.27M
    Net Cash Flow
    		 1.08M -18.73M 10.6M 3.27M
    Free Cash Flow
    		 -14.49M -28.72M -20.66M -11.02M

    Add to Watchlist